Replies to post #71690 on Avid Bioservices Inc (CDMO)

[Edward Munch]

Agree. Huge potential.

[pphmtoolong]

Two more major data points to come in December: FDA meeting on Cotara and HCV trial results. If they are both good, I hope/expect the PPS should blow by $2.

However, we need a BP partner. If we get one of those, we just might make some real money. All IMHO.

Paul